QTMeds

Drug Database Monograph

EMGALITY 120 mg

PENDING REVIEW

Active Ingredient: GALCANEZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 69972332

← Back to Prescription Analyzer